Screening of Type 2 Diabetes Patients of Khyber Pakhtunkhwa for CDKAL1 Variant (rs10946398)

T2DM Screening for CDKAL1 Variant (rs10946398)

Authors

  • Maqsood Ali Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
  • Haji Bahadar Institute of Pharmaceutical Sciences, Khyber Medical University, Peshawar, Pakistan
  • Haseenullah Shah Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
  • Sajjad Afridi Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
  • Sajid Ali Department of Biotechnology, Abdul Wali Khan University, Mardan, Pakistan
  • Kiran Ijaz Institute of Pharmaceutical Sciences, Khyber Medical University, Peshawar, Pakistan
  • Fazli Khuda Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
  • Hamayun Khan Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
  • Mohsin Raziq Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
  • . Zakiullah Department of Pharmacy, University of Peshawar, Peshawar, Pakistan

DOI:

https://doi.org/10.54393/pbmj.v7i03.1050

Keywords:

CDKAL1 Gene, Diabetes Mellitus, Familial History, Genetic Predispositions

Abstract

Diabetes Mellitus Type 2 (T2DM) is a metabolic disorder influenced by environmental and genetic factors, with varied genetic predispositions across populations. Research on T2DM's genetic risk factors in the Pakistani community is limited. Objective: To explore the association between the CDKAL1 gene variant (rs10946398) and T2DM in the Khyber Pakhtunkhwa population in Pakistan. Methods: The study involved 100 T2DM patients and 100 controls, matched by age and gender, following specific inclusion and exclusion criteria. Sociodemographic data were collected alongside 3ml of whole blood for DNA extraction. The CDKAL1 gene was analyzed using PCR-based Sequence Restriction Fragment Length Polymorphism (RFLP), and the data were processed with SPSS version 26.0s. Results: Findings showed that 47% of cases were aged 39 to 59, with 94% having a family history of T2DM and 85% leading a sedentary lifestyle. A significant association was observed between the CDKAL1 rs10946398 variant and T2DM. The GC variant was linked to a fourfold increase in risk (OR: 4.833, CI: 1.197-19.509, P=0.027), and the CC variant had a twofold association (OR: 2.788, CI: 1.545-5.033, P=0.001). These associations persisted after adjusting for family history, age, socioeconomic factors, exercise, and diet. Conclusions: The study identified a significant correlation between the CDKAL1 rs10946398 variants and T2DM susceptibility in the Khyber Pakhtunkhwa population, emphasizing the role of genetic factors in the disease's prevalence within this community.

 

References

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010 Jan; 33(Supplement_1): S62-9. doi: 10.2337/dc10-S062. DOI: https://doi.org/10.2337/dc10-S062

Care D. Classification and diagnosis of diabetes. Diabetes Care. 2017 Jan1; 40(Suppl 1): S11-24. doi: 10.2337/dc17-S005. DOI: https://doi.org/10.2337/dc17-S005

Tattersall RB, and Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes. 1975 Jan; 24(1): 44-53. doi: 10.2337/diabetes.24.1.44. DOI: https://doi.org/10.2337/diabetes.24.1.44

Dall TM, Yang W, Halder P, Pang B, Massoudi M, Wintfeld N et al. The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care. 2014 Dec; 37(12): 3172-9. doi: 10.2337/dc14-1036. DOI: https://doi.org/10.2337/dc14-1036

Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice. 2011 Dec; 94(3): 311-21. doi: 10.1016/j.diabres.2011.10.029. DOI: https://doi.org/10.1016/j.diabres.2011.10.029

Peixoto-Barbosa R, Reis AF, Giuffrida FM. Update on clinical screening of maturity-onset diabetes of the young (MODY). Diabetology & Metabolic Syndrome. 2020 Dec; 12: 1-4. doi: 10.1186/s13098-020-00557-9. DOI: https://doi.org/10.1186/s13098-020-00557-9

Ahlqvist E, Ahluwalia TS, Groop L. Genetics of type 2 diabetes. Clinical Chemistry. 2011 Feb; 57(2): b241-54. doi: 10.1373/clinchem.2010.157016. DOI: https://doi.org/10.1373/clinchem.2010.157016

Liu X, Liang J, Geng H, Xu W, Teng F, Yang M. Association of the CDKAL1 polymorphism rs10946398 with type 2 diabetes mellitus in adults: A meta-analysis. Medicine. 2020; 99: e21383. doi: 10.1097/MD.0000000000021383. DOI: https://doi.org/10.1097/MD.0000000000021383

Brambillasca S, Altkrueger A, Colombo SF, Friederich A, Eickelmann P, Mark M et al. CDK5 regulatory subunit-associated protein 1-like 1 (CDKAL1) is a tail-anchored protein in the endoplasmic reticulum (ER) of insulinoma cells. Journal of Biological Chemistry. 2012 Dec; 287(50): 41808-19. doi: 10.1074/jbc.M112.376558. DOI: https://doi.org/10.1074/jbc.M112.376558

Noury AE, Azmy O, Alsharnoubi J, Salama S, Okasha A, Gouda W. Variants of CDKAL1 rs7754840 (G/C) and CDKN2A/2B rs10811661 (C/T) with gestational diabetes: insignificant association. BMC Research Notes. 2018 Dec; 11: 1-6. doi: 10.1186/s13104-018-3288-7. DOI: https://doi.org/10.1186/s13104-018-3288-7

Asghar A, Firasat S, Afshan K, Naz S. Association of CDKAL1 gene polymorphism (rs10946398) with gestational diabetes mellitus in Pakistani population. Molecular Biology Reports. 2023 Jan; 50(1): 57-64. doi: 10.1007/s11033-022-08011-x. DOI: https://doi.org/10.1007/s11033-022-08011-x

Fahim NK, Negida A, Fahim AK. Sample size calculation guide-part 3: how to calculate the sample size for an independent case-control study. Frontiers in Emergency Medicine. 2019 Feb; 3(2): e20.

Rink G, Scharberg EA, Bugert P. PCR with sequence-specific primers for typing of diallelic blood groups. Molecular Typing of Blood Cell Antigens. 2015: 71-81. 10.1007/978-1-4939-2690-9_6. DOI: https://doi.org/10.1007/978-1-4939-2690-9_6

van Niel J, Geelhoed‐Duijvestijn PH, Numans ME, Kharagjitsingh AV, Vos RC. Type 2 diabetes in South Asians compared to Europeans: Higher risk and earlier development of major cardiovascular events irrespective of the presence and degree of retinopathy. Results from The HinDu The Hague Diabetes Study. Endocrinology, Diabetes & Metabolism. 2021; 4(3): e00242. doi: 10.1002/edm2.242. DOI: https://doi.org/10.1002/edm2.242

Liu Y, Yu L, Zhang D, Chen Z, Zhou DZ, Zhao T et al. Positive association between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals. Diabetologia. 2008 Nov; 51: 2134-7. doi: 10.1007/s00125-008-1141-6. DOI: https://doi.org/10.1007/s00125-008-1141-6

Wu Y, Li H, Loos RJ, Yu Z, Ye X, Chen L et al. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes. 2008 Oct; 57(10): 2834-42. doi: 10.2337/db08-0047. DOI: https://doi.org/10.2337/db08-0047

Lee YH, Kang ES, Kim SH, Han SJ, Kim CH, Kim HJ et al. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. Journal of Human Genetics. 2008 Dec; 53(11):991-8. doi: 10.1007/s10038-008-0341-8. DOI: https://doi.org/10.1007/s10038-008-0341-8

Vatankhah Yazdi K, Kalantar SM, Houshmand M, Rahmanian M, Manaviat MR, Jahani MR et al. SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are associated with type 2 diabetes mellitus in Iranian patients. Diabetes, Metabolic Syndrome and Obesity. 2020 Mar: 897-906. doi: 10.2147/DMSO.S225968. DOI: https://doi.org/10.2147/DMSO.S225968

Lewis JP, Palmer ND, Hicks PJ, Sale MM, Langefeld CD, Freedman BI et al. Association analysis in African Americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes. 2008 Aug; 57(8): 2220-5. doi: 10.2337/db07-1319. DOI: https://doi.org/10.2337/db07-1319

Dehwah MA, Wang M, Huang QY. CDKAL1 and type 2 diabetes: a global meta-analysis. Genetics and Molecular Research. 2010 Jun; 9(2): 1109-20. doi: 10.4238/vol9-2gmr802. DOI: https://doi.org/10.4238/vol9-2gmr802

Nfor ON, Wu MF, Lee CT, Wang L, Liu WH, Tantoh DM et al. Body mass index modulates the association between CDKAL1 rs10946398 variant and type 2 diabetes among Taiwanese women. Scientific Reports. 2018 Sep; 8(1): 13235. doi: 10.1038/s41598-018-31415-4. DOI: https://doi.org/10.1038/s41598-018-31415-4

Herder C, Rathmann W, Strassburger K, Finner H, Grallert H, Huth C et al. Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies. Hormone and Metabolic Research. 2008 Jul: 722-6. doi: 10.1055/s-2008-1078730. DOI: https://doi.org/10.1055/s-2008-1078730

Verma AK, Beg MM, Khan NA, Goyal Y, Dev K, Joshi PC. CDKAL1 (rs10946398) and TCF7L2 (rs7903146) gene polymorphisms and their association with risk of type-2 diabetes mellitus in population of Uttarakhand, India. Meta Gene. 2020 Dec; 26: 100767. doi: 10.1016/j.mgene.2020.100767. DOI: https://doi.org/10.1016/j.mgene.2020.100767

Al Ali M, El hajj Chehadeh S, Osman W, Almansoori K, Abdulrahman M, Tay G et al. Investigating the association of rs7903146 of TCF7L2 gene, rs5219 of KCNJ11 gene, rs10946398 of CDKAL1 gene, and rs9939609 of FTO gene with type 2 diabetes mellitus in Emirati population. Meta Gene. 2019 Sep; 21: 100600. doi: 10.1016/j.mgene.2019.100600. DOI: https://doi.org/10.1016/j.mgene.2019.100600

Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes. 2008 Mar; 57(3): 791-5. doi: 10.2337/db07-0979. DOI: https://doi.org/10.2337/db07-0979

Kang J, Guan RC, Zhao Y, Chen Y. Obesity-related loci in TMEM18, CDKAL1 and FAIM2 are associated with obesity and type 2 diabetes in Chinese Han patients. BMC Medical Genetics. 2020 Dec; 21: 1-8. doi: 10.1186/s12881-020-00999-y. DOI: https://doi.org/10.1186/s12881-020-00999-y

Downloads

Published

2024-03-31
CITATION
DOI: 10.54393/pbmj.v7i03.1050
Published: 2024-03-31

How to Cite

Ali, M., Bahadar, H., Shah, H., Afridi, S., Ali, S., Ijaz, K., Khuda, F., Khan, H., Raziq, M., & Zakiullah, . (2024). Screening of Type 2 Diabetes Patients of Khyber Pakhtunkhwa for CDKAL1 Variant (rs10946398): T2DM Screening for CDKAL1 Variant (rs10946398). Pakistan BioMedical Journal, 7(03), 43–49. https://doi.org/10.54393/pbmj.v7i03.1050

Issue

Section

Original Article

Plaudit